Provided by Tiger Trade Technology Pte. Ltd.

Catalyst Pharmaceuticals

23.40
-0.8500-3.51%
Post-market: 23.400.00000.00%19:53 EDT
Volume:754.84K
Turnover:17.82M
Market Cap:2.86B
PE:13.93
High:24.29
Open:24.15
Low:23.39
Close:24.25
52wk High:26.58
52wk Low:19.05
Shares:122.12M
Float Shares:115.02M
Volume Ratio:0.51
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.68
EPS(LYR):1.68
ROE:25.49%
ROA:16.48%
PB:2.99
PE(LYR):13.93

Loading ...

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Nov 13, 2025

Catalyst Pharmaceuticals Inc. Stock Advances 7.1%, Outperforms Peers

Dow Jones
·
Nov 12, 2025

Catalyst Pharmaceuticals (CPRX): Valuation Insights After Strong Q3 Results and New Share Buyback Program

Simply Wall St.
·
Nov 09, 2025

Catalyst Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
Nov 08, 2025

Stock Track | Catalyst Pharmaceuticals Soars 5.10% Pre-Market on Analyst Upgrades and Bullish Outlook

Stock Track
·
Nov 07, 2025

Catalyst Pharmaceuticals price target raised to $33 from $32 at Oppenheimer

TIPRANKS
·
Nov 07, 2025

Catalyst Pharmaceuticals, Inc. : Oppenheimer Raises Target Price to $33 From $32

THOMSON REUTERS
·
Nov 07, 2025

Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Nov 07, 2025

Stock Track | Catalyst Pharmaceuticals Soars 6.36% After-Hours on Strong Q3 Results, Raised Guidance, and Share Buyback

Stock Track
·
Nov 06, 2025

Stock Track | Catalyst Pharmaceuticals Soars 6.36% After Hours on Strong Q3 Results, Raised Guidance

Stock Track
·
Nov 06, 2025

BRIEF-Catalyst Pharmaceuticals Q3 Revenue USD 148.4 Million Vs. IBES Estimate USD 136.8 Million

Reuters
·
Nov 06, 2025

Santhera Pharmaceuticals Closes $13 Million Royalties Agreement to Support AGAMREE Launch

Reuters
·
Nov 05, 2025

Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work

GlobeNewswire
·
Nov 05, 2025

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

GlobeNewswire
·
Nov 03, 2025

Catalyst Pharmaceuticals (CPRX): Assessing Valuation on Steady Performance and Long-Term Growth Potential

Simply Wall St.
·
Nov 02, 2025

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 01, 2025

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 30, 2025

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 28, 2025

Catalyst Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
Oct 25, 2025

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 23, 2025